Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin Withdrawal in VKA-Treated Hemodialysis Patients (REMARK)
NCT04462614Unknown
- Sponsor
- CHU de Reims
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial of heparin in end stage renal disease (ESRD), sponsored by CHU de Reims. Primary endpoint: Failure of heparin withdrawal in patients treated by long-term anticoagulation with VKA and dialysed with the HeprAN membrane at 3 weeks. Status: unknown.
02
Drugs
heparin
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT04462614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462614.